-
Arpana Agrawal, Ph.D.
- Genetic and environment studies of addictions
-
John P. Atkinson, M.D.
- Complement activation and regulation in innate and adaptive immunity
-
Laura J. Bierut, M.D.
- Family and genetic studies of psychiatric illnesses and substance dependence (alcoholism, smoking, and cocaine dependence)
-
Ryan Bogdan, Ph.D.
- How genetic variation and environmental experience contribute to individual differences in brain function, behavior, and psychopathology
-
Kelly L. Bolton, M.D., Ph.D.
- The interplay between inherited genetic variation, environmental factors, and acquired mutations in shaping the earliest stages of carcinogenesis
-
Michael R. Brent, Ph.D.
- Systems biology, transcriptional regulatory networks, network inference, yeast
-
Yin Cao, Sc.D., MPH
- Novel lifestyle, microbial, and genetic risk factors for gastrointestinal cancers leveraging large-scale clinical and population-based cohorts with deep genetic and phenotypic data
-
Aadel A. Chaudhuri, M.D., Ph.D.
- Liquid biopsy cancer detection
-
F. Sessions Cole, M.D.
- Genetic lung disease, Surfactant protein B, and rare diseases in infants
-
John N. Constantino, M.D.
- social development; autism spectrum disorder; child maltreatment; attachment; developmental disorders
-
Megan A. Cooper, M.D., Ph.D.
- The biology of natural killer (NK) cells and genetic investigation of primary immune dysregulation syndromes
-
Sharon Cresci, M.D.
- Genetic variation in the variable response to pharmacologic treatment (i.e. Pharmacogenomics) of cardiovascular disease; specifically individuals with both diabetes mellitus and coronary artery disease.
-
Carlos Cruchaga, Ph.D.
- The goal of my lab is to understand the biology of neurodegeneration by using high-dimensional omic data and functional genomic approaches.
-
Li Ding, Ph.D.
- Cancer genomics and proteomics
-
Gerald W. Dorn, II, M.D.
- Cellular, Molecular, And Genetic Studies Of Cardiac Hypertrophy And Heart Failure
-
Joseph D. Dougherty, Ph.D.
- Human Psychiatric Genetics, Mouse Models, Cell Type Specific Gene Expression Profiling, Translation, Astrocytes.
-
Bettina F. Drake, Ph.D., M.P.H.
- Identifying preventive strategies to reduce cancer disparities
-
Susan K. Dutcher, Ph.D.
-
John R. Edwards, Ph.D.
- Understanding epigenomic abnormalities in breast cancer
-
Stephanie A. Fritz, M.D., MSCI
- Asking and answering critical questions to guide clinical practice and ameliorate childhood suffering due to staphylococcal disease
-
Obi L. Griffith, Ph.D.
- Development of personalized medicine strategies for cancer using genomic technologies
-
C. Charles Gu, Ph.D.
- Statistical genetics and bioinformatics, high-dimensional data analysis and complex systems modeling, developing novel methodologies for detecting complex disease genes and characterizing their function
-
Christina A. Gurnett, M.D., Ph.D.
- Gene discovery, variant interpretation using high-throughput functional assays
-
Gabriel Haller, Ph.D.
- Genetic underpinnings of multiple neurological/neurosurgical disorders
-
Oscar M. Harari, Ph.D.
- Identification of "omics" (proteomic, transcriptomic and genetic) factors associated with neurodegeneration
-
Andrew C. Heath, D.Phil.
- Genetic studies of alcoholism, smoking and drug dependence, depression, suicidality and anxiety disorders, personality disorders, and methodological research in genetic epidemiology
-
Aimee S. James, Ph.D., M.P.H.
- Cancer prevention and control, health disparities and community-based research
-
Sheng Chih (Peter) Jin, Ph.D.
- We use human genetic, genomic, and bioinformatic approaches to identify mutations underlying human diseases and their molecular mechanisms
-
Heather A. Lawson, Ph.D.
- Integration of whole-genome sequence with phenotypic data to understand parent-of-origin genetic effects and gene-by-environment interactions
-
Christopher Maher, Ph.D.
- Translational Cancer Genomics; Noncoding RNAs
-
Allegra A. Petti, Ph.D.
- We seek to understand tumor ecosystems at single-cell resolution during the development and evolution of human cancer
-
Michael A. Province, Ph.D.
- Mathematical development of new statistical genetics methodology for complex traits
-
D.C. Rao, Ph.D.
- Statistical genetic analysis of cardiovascular disease traits using GxG and GxE interactions
-
John P. Rice, Ph.D.
- Statistical genetics; complex disease genetics; methods in statistical genetics
-
Eli Roberson, Ph.D.
- Using bench molecular biology, high-throughput sequencing, and bioinformatics to understand human inflammatory / autoimmune disease.
-
Nancy L. Saccone, Ph.D.
- Statistical genetics, complex human diseases, analysis methods
-
Matthew J. Silva, Ph.D.
- Skeletal mechanobiology, bone strength, bone injury and repair
-
Nathan Stitziel, M.D., Ph.D.
- We try understand the inherited basis underlying cardiovascular disease and leverage insights from our work to improve patient care.
-
Gary D. Stormo, Ph.D.
- Computational biology, bioinformatics, protein-DNA interactions, gene regulation
-
Cristina de Guzman Strong, Ph.D.
- Genomics of Skin Barrier: Development and Disease
-
Adetunji T. Toriola, M.D., Ph.D.
- Associations of metabolic imbalance, inflamation with cancer etiology and survival
-
Tychele N. Turner, Ph.D.
- Discovery and characterization of genetic etiological factors involved in neurodevelopmental disorders
-
Ting Wang, Ph.D.
- Epigenome evolution and epigenetic determinants of cell fate
-
Mark A. Watson, M.D., Ph.D.
- Use of microarray technology and other 'whole-genome' approaches to molecularly classify human malignancies and to identify genetic pathways associated with tumor progression
-
Elizabeth L. Yanik, Ph.D.
- Discovering new insights into the etiology and progression of rotator cuff disease in order to directly inform clinical decision-making and prevention approaches.
|
|